India to Kenya: Bevacizumab Export Trade Route

The India to Kenya Bevacizumab corridor is one of India's established pharmaceutical export routes, with 184 shipments documented worth a combined $930.4K USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's bevacizumab manufacturing sector.

Across 27 active suppliers, the average shipment value stands at $5.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with bevacizumab's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 29.6%, placing it at rank #7 among India's top bevacizumab export destinations globally.

On the import side, key buyers of Indian bevacizumab in Kenya include NA, TO, M/S. SURGILINKS LIMITED., and 32 others. NA is the single largest importer with 10 shipments valued at $351.8K USD.

India's bevacizumab exports to Kenya are driven primarily by a handful of large-scale manufacturers. DR.REDDY'S LABORATORIES LTD with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 27 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, R.S. SURGIPHARM PRIVATE LIMITED, MYLAN PHARMACEUTICALS PRIVATE LIMITED — together account for 60% of total trade value on this route. The average shipment value of $5.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as bevacizumab 400mg inj (1 vial) and bevacizumab csi 400mg/16ml 1 vl in my , suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 10 shipments worth $351.8K USD — representing 38% of all bevacizumab imports from India on this route. A total of 35 buyers are active on this corridor.